Quick Answer
Boundless Bio, Inc. reported Net Income of -$58.20 million for fiscal year 2025.
Boundless Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$58.20M | +11.0% |
| 2024 | -$65.36M | -32.2% |
| 2023 | -$49.43M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.88M | +15.9% | +11.5% |
| June 30, 2025 | -$15.68M | +7.7% | +0.5% |
| March 31, 2025 | -$15.76M | -2.1% | +4.5% |
| September 30, 2024 | -$16.51M | -25.3% | +2.8% |
| June 30, 2024 | -$16.98M | -36.9% | -10.0% |
| March 31, 2024 | -$15.43M | -31.7% | -17.1% |
| September 30, 2023 | -$13.17M | — | -6.3% |
| June 30, 2023 | -$12.40M | — | -5.8% |
- Boundless Bio, Inc. showed an increase of +11.0% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, Boundless Bio, Inc.’s net income has declined by 17.7% (from -$49.43 million to -$58.20 million).
- The most recent figure is from Boundless Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: